Deutsche Bank downgrades United Therapeutics (Nasdaq: UTHR) from Buy to Hold. Price target lowered from $105 to $70.

This article: 215 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE